Maureen Anderson

735 total citations
18 papers, 601 citations indexed

About

Maureen Anderson is a scholar working on Surgery, Molecular Biology and Biochemistry. According to data from OpenAlex, Maureen Anderson has authored 18 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Surgery, 8 papers in Molecular Biology and 4 papers in Biochemistry. Recurrent topics in Maureen Anderson's work include Lipoproteins and Cardiovascular Health (9 papers), Cholesterol and Lipid Metabolism (8 papers) and Lipid metabolism and biosynthesis (4 papers). Maureen Anderson is often cited by papers focused on Lipoproteins and Cardiovascular Health (9 papers), Cholesterol and Lipid Metabolism (8 papers) and Lipid metabolism and biosynthesis (4 papers). Maureen Anderson collaborates with scholars based in United States, Canada and Argentina. Maureen Anderson's co-authors include Reynold Homan, Brian R. Krause, Drago R. Sliskovic, Richard F. Bousley, Richard L. Stanfield, Katherine L. Hamelehle, Joseph A. Picard, Patrick O’Brien, Douglas B. Kintner and Pierre R. Fobert and has published in prestigious journals such as Circulation Research, Journal of Medicinal Chemistry and Journal of Nutrition.

In The Last Decade

Maureen Anderson

18 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maureen Anderson United States 12 263 144 82 80 70 18 601
Rashmeet K. Reen United States 20 338 1.3× 94 0.7× 44 0.5× 110 1.4× 55 0.8× 33 1.1k
J.M. Dypbukt Sweden 9 463 1.8× 98 0.7× 81 1.0× 47 0.6× 43 0.6× 11 838
Tamás Kriska United States 14 303 1.2× 65 0.5× 92 1.1× 33 0.4× 46 0.7× 37 735
Margaret H. Marino United States 8 328 1.2× 207 1.4× 64 0.8× 120 1.5× 48 0.7× 9 1.0k
James H. Dyer United States 10 438 1.7× 191 1.3× 98 1.2× 134 1.7× 13 0.2× 13 647
Caroline Camaré France 13 304 1.2× 83 0.6× 36 0.4× 48 0.6× 69 1.0× 15 774
Dev K. Singh United States 16 458 1.7× 248 1.7× 36 0.4× 110 1.4× 20 0.3× 25 855
Cassandra L. Henry United States 11 285 1.1× 70 0.5× 30 0.4× 44 0.6× 49 0.7× 13 657
Enas M. Moustafa Egypt 14 220 0.8× 47 0.3× 34 0.4× 77 1.0× 26 0.4× 37 520
Sachiko Takaishi Japan 11 306 1.2× 37 0.3× 31 0.4× 55 0.7× 66 0.9× 11 525

Countries citing papers authored by Maureen Anderson

Since Specialization
Citations

This map shows the geographic impact of Maureen Anderson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maureen Anderson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maureen Anderson more than expected).

Fields of papers citing papers by Maureen Anderson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maureen Anderson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maureen Anderson. The network helps show where Maureen Anderson may publish in the future.

Co-authorship network of co-authors of Maureen Anderson

This figure shows the co-authorship network connecting the top 25 collaborators of Maureen Anderson. A scholar is included among the top collaborators of Maureen Anderson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maureen Anderson. Maureen Anderson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Cremonini, Eleonora, Angela Mastaloudis, Shelly N. Hester, et al.. (2017). Anthocyanins inhibit tumor necrosis alpha-induced loss of Caco-2 cell barrier integrity. Food & Function. 8(8). 2915–2923. 66 indexed citations
2.
Anderson, Maureen, Arvind Kumar, Yan Zhang, et al.. (2008). Transgenic increases in seed oil content are associated with the differential expression of novel Brassica-specific transcripts. BMC Genomics. 9(1). 619–619. 41 indexed citations
3.
Jadhav, Ashok, David C. Taylor, Michael Giblin, et al.. (2008). Hormonal regulation of oil accumulation in Brassica seeds: Metabolism and biological activity of ABA, 7′-, 8′- and 9′-hydroxy ABA in microspore derived embryos of B. napus. Phytochemistry. 69(15). 2678–2688. 34 indexed citations
5.
Rekhter, Mark D., David W. Brammer, Hussein Hallak, et al.. (2000). Hypercholesterolemia Causes Mechanical Weakening of Rabbit Atheroma. Circulation Research. 86(1). 101–108. 61 indexed citations
7.
Homan, Reynold & Maureen Anderson. (1998). Rapid separation and quantitation of combined neutral and polar lipid classes by high-performance liquid chromatography and evaporative light-scattering mass detection. Journal of Chromatography B Biomedical Sciences and Applications. 708(1-2). 21–26. 141 indexed citations
8.
Krause, Brian R., Drago R. Sliskovic, Maureen Anderson, & Reynold Homan. (1998). Lipid‐lowering effects of WAY‐121,898, an inhibitor of pancreatic cholesteryl ester hydrolase. Lipids. 33(5). 489–98. 30 indexed citations
9.
Picard, Joseph A., Maureen Anderson, Sandra Bak Mueller, et al.. (1996). Heterocyclic Amides:  Inhibitors of Acyl-CoA:Cholesterol O-Acyl Transferase with Hypocholesterolemic Activity in Several Species and Antiatherosclerotic Activity in the Rabbit. Journal of Medicinal Chemistry. 39(20). 3908–3919. 12 indexed citations
10.
O’Brien, Patrick, Drago R. Sliskovic, Joseph A. Picard, et al.. (1996). Inhibitors of Acyl-CoA:Cholesterol O-Acyltransferase. Synthesis and Pharmacological Activity of (±)-2-Dodecyl-α-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5-acetamide and Structurally Related Tetrazole Amide Derivatives. Journal of Medicinal Chemistry. 39(12). 2354–2366. 29 indexed citations
11.
White, Andrew D., Maureen Anderson, Thomas Bocan, et al.. (1996). Tetrazole-substituted ureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT). A novel preparation of ureas from weakly nucleophilic amines. Bioorganic & Medicinal Chemistry Letters. 6(15). 1753–1758. 4 indexed citations
12.
Picard, Joseph A., Patrick O’Brien, Drago R. Sliskovic, et al.. (1996). Inhibitors of Acyl-CoA:CholesterolO-Acyltransferase. 17. Structure−Activity Relationships of Several Series of Compounds Derived fromN-Chlorosulfonyl Isocyanate. Journal of Medicinal Chemistry. 39(6). 1243–1252. 45 indexed citations
13.
Roth, Bruce D., W. Howard Roark, Joseph A. Picard, et al.. (1995). Inhibitors of acyl-coa:cholesterol acyltransferase (ACAT). 15. sulfonylurea inhibitors with excellent hypocholesterolemic activity in vivo.. Bioorganic & Medicinal Chemistry Letters. 5(20). 2367–2370. 7 indexed citations
14.
15.
O’Brien, Patrick, Drago R. Sliskovic, Maureen Anderson, et al.. (1995). Inhibitors of acyl-CoA: Cholesterol O-acyl transferase (ACAT) as hypocholesterolemic agents. 12. Syntheses and biological activity of structurally novel tetrazole amides. Bioorganic & Medicinal Chemistry Letters. 5(3). 289–294. 4 indexed citations
16.
Sliskovic, Drago R., Brian R. Krause, Joseph A. Picard, et al.. (1994). Inhibitors of Acyl-CoA:cholesterol O-Acyl Transferase (ACAT) as Hypocholesterolemic Agents.6.The First Water-Soluble ACAT Inhibitor with Lipid-Regulating Activity. Journal of Medicinal Chemistry. 37(5). 560–562. 32 indexed citations
18.
Hobbs, S. L. A., Lawrence E. Pelcher, Catherine DeLong, Maureen Anderson, & J. D. Mahon. (1990). Genetic variability in the amount of ribulose-1,5-bisphosphate carboxylase/oxygenase and its small subunit mRNA in pea. Planta. 180(4). 510–516. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026